Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. https://t.co/eemXpnmcZt
1,219 followers
1,489 followers
RT @jitcancer: #JITC Research: Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or un…
8,406 followers
RT @__ice9: Relatedly: I still see strong indications that an anti-IL-8 mAb would likely be helpful in treating this disease. Currently,…
8,406 followers
Relatedly: I still see strong indications that an anti-IL-8 mAb would likely be helpful in treating this disease. Currently, there are none on the market. https://t.co/7wiDo6gIzF https://t.co/DMwvrRX923 https://t.co/ORgufq1oRH https://t.co/4lnSK9cF0n